Dividend-adjusted total return · S&P 500 uses VOO · Oct 31, 2023 – Nov 5, 2026ARKGS&P 500 · VOO
| Returns | 1D | 1M | 3M | YTD | 1Y | 3Y | 5Y | MAX |
|---|---|---|---|---|---|---|---|---|
| Total return | −10.2% | −11.0% | +3.7% | +54.0% | +51.3% | +93.8% | −41.4% | +139.8% |
| Peer average | −3.4% | +4.6% | +3.5% | +19.7% | +29.0% | +75.3% | +27.3% | — |
| S&P 500 · VOO | −4.4% | −5.7% | −4.9% | +8.4% | +9.8% | +82.2% | +71.6% | — |
Key Statistics
Open all fund facts →- AUM
- $2.2B
- Expense ratio
- 0.75%
- Distribution yield
- 0.0%
- NAV
- $49.74
- Volume
- 7.5M
- Avg. volume 30D
- 5.7M
- High today
- $47.87
- Low today
- $43.89
- Previous close
- $49.69
- 52-week high
- $58.83
- 52-week low
- $24.60
- Our risk indicator
- 4/5
ARKG in One Breath
ARKG Among Health Care ETFs
YTDEnd-of-day Nov 6, 2026 · 33 Health care ETFs by YTD
$10,000 in ARKG
5Y$10,000 in ARKG became
$5,859
In the S&P 500 (VOO)
$17,156
Total return, dividends in · Oct 28, 2021 – Nov 5, 2026 · S&P 500 uses VOO
ARKG’s Top Holdings
TodayTEMTempus Ai -9.2%TXG8.0%TWST8.0%CRSP5.5%ABSI5.3%GH4.9%NTRA4.7%LLY4.5%ILMN4.2%CDNA4.2%BEAM4.0%VCYT3.9%SDGR3.1%RXRX2.9%ADPT2.4%CMPS2.3%NRIX2.0%NTLA1.9%WGS1.9%PRME1.9%IONS1.7%BFLYOther
BiotechnologyMedical - DiagnosticsMedical - Healthcare Information ServicesDrug Manufacturers - GeneralSoftware - ApplicationMedical - Devices
ARK ARKG · 10 holdings · tile size = share of the fund · as of Nov 5, 2026
What ARKG Holds
TodayBiotechnology50.6%
TXG 8.0 · TWST 8.0 · CRSP 5.5 · ABSI 5.3 · BEAM 4.0 · RXRX 2.9 · ADPT 2.4
Medical - Diagnostics & Research24.8%
GH 4.9 · NTRA 4.7 · ILMN 4.2 · CDNA 4.2 · VCYT 3.9 · WGS 1.9 · FRNM
Medical - Healthcare Information Services9.2%
TEM 9.2
Drug Manufacturers - General4.5%
LLY 4.5
Software - Application4.0%
SDGR 3.1 · IAM
Medical - Devices3.9%
BFLY 1.6 · PACB 1.4 · CERS
Medical - Specialties1.0%
MASS 1.0
ARK ARKG · share of the fund by industry · as of Nov 5, 2026
Tempus’ Share of ARKG
Today9.2%
$92 of every $1,000 in ARKG is Tempus
Tempus held by ARKG
$204M
ARK ARKG · each square = $10 of $1,000 · as of Nov 5, 2026
ARKG’s Share of Health Care ETFs
Today2.0%
of the $112B in 39 Health care ETFs
$2.2B2.0%
$50.9B45.4%
$19.1B17.0%
$39.9B35.6%
Health care ETF AUM · Nov 6, 2026
ARKG Fee per $100 vs Peers
TodayExpense ratio · Health care peers · Nov 6, 2026
Inside ARKG
10 holdings · as of Nov 5, 2026ARKG
ARK Genomic Revolution ETF
TodayBiotechnology50.6%TXG8.0%TWST8.0%CRSP5.5%ABSI5.3%BEAM4.0%RXRX2.9%ADPT2.4%CMPS2.3%NRIXNTLA1.9%PRME1.9%IONSARCTALMR2 moreMedical - Diagnostics24.8%GH4.9%NTRA4.7%ILMN4.2%CDNA4.2%VCYT3.9%WGS1.9%FRNMMedical - Healthcare Information Services9.2%TEM9.2%Drug Manufacturers - General4.5%LLY4.5%Software - Application4.0%SDGR3.1%IAMMedical - Devices3.9%BFLYPACBCERSMASSOther1.9%SCTXQSI
Biotechnology50.6%TXG8.0%TWST8.0%CRSP5.5%ABSI5.3%BEAM4.0%RXRX2.9%10 more holdings17.0% of the fundMedical - Diagnostics24.8%GH4.9%NTRA4.7%ILMN4.2%CDNA4.2%VCYT3.9%WGSMedical - Healthcare Information Services9.2%TEM9.2%Drug Manufacturers - General4.5%LLYSoftware - Application4.0%SDGRMedical - Devices3.9%BFLYPACBMASSSCTX
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | TEM | Tempus AI - | 9.20% |
| 2 | TXG | 10X Genomics - | 7.99% |
| 3 | TWST | Twist Bioscience | 7.95% |
| 4 | CRSP | Crispr Therapeutics AG | 5.51% |
| 5 | ABSI | Absci | 5.32% |
| 6 | GH | Guardant Health | 4.91% |
| 7 | NTRA | Natera | 4.67% |
| 8 | LLY | ELI Lilly & | 4.48% |
| 9 | ILMN | Illumina | 4.25% |
| 10 | CDNA | Caredx | 4.19% |
BiotechnologyMedical - DiagnosticsMedical - Healthcare Information ServicesDrug Manufacturers - GeneralSoftware - ApplicationMedical - DevicesMedical - SpecialtiesOther
ARK ARKG · current holdings by weight · as of Nov 5, 2026 · each tile is one holding · top 20 = 84.7%
All ARKG Holdings
35 holdings · as of Nov 5, 2026ARKG
ARKG’s Holdings
Today| # | ||||||
|---|---|---|---|---|---|---|
| 1 | TEMTempus AI | Healthcare | 9.20% | $920.22 | 2.7M | $201.4M |
| 2 | TXG10X Genomics | Healthcare | 7.99% | $799.21 | 2.6M | $175.0M |
| 3 | TWSTTwist Bioscience | Healthcare | 7.95% | $795.37 | 1.2M | $174.1M |
| 4 | CRSPCrispr Therapeutics AG | Healthcare | 5.51% | $550.84 | 2.3M | $120.6M |
| 5 | ABSIAbsci | Healthcare | 5.32% | $532.43 | 11.1M | $116.6M |
| 6 | GHGuardant Health | Healthcare | 4.91% | $491.31 | 638K | $107.6M |
| 7 | NTRANatera | Healthcare | 4.67% | $467.15 | 262K | $102.3M |
| 8 | LLYELI Lilly | Healthcare | 4.48% | $447.70 | 69K | $98.0M |
| 9 | ILMNIllumina | Healthcare | 4.25% | $424.93 | 411K | $93.0M |
| 10 | CDNACaredx | Healthcare | 4.19% | $418.55 | 1.1M | $91.6M |
| 11 | BEAMBEAM Therapeutics | Healthcare | 4.00% | $400.46 | 3.2M | $87.7M |
| 12 | VCYTVeracyte | Healthcare | 3.95% | $394.74 | 1.6M | $86.4M |
| 13 | SDGRSchrodinger | Technology | 3.10% | $309.81 | 2.4M | $67.8M |
| 14 | RXRXRecursion Pharmaceuticals | Healthcare | 2.86% | $286.09 | 16.1M | $62.6M |
| 15 | ADPTAdaptive Biotechnologies | Healthcare | 2.36% | $235.86 | 1.9M | $51.6M |
ARK ARKG · every reported holding · per $10,000 = dollars of each holding in a $10,000 stake · as of Nov 5, 2026
How It Compares
ARKG
ARK Genomic Revolution ETF’s Peers
YTDHealth care peers · YTD and past-year returns · as of Nov 6, 2026 · sorted by AUM
Head to Head
Put ARKG head to head with XLV →XLV vs ARKG
YTDYear to date
ARKG wins+33.1 pts
Past year
ARKG wins+21.7 pts
Fee
XLV winslower fee
Yield
XLV wins+1.4 pts
AUM
XLV23.0× more
2–2level
SPDR XLV and ARK ARKG · year-to-date · as of Nov 6, 2026 · AUM not scored
ARKG vs VOO
YTDARKG · ARK Genomic Revolution
+54.0%
VOO · S&P 500
+8.4%
Gap
45.6 pts
ARK ARKG and Vanguard VOO · YTD total return · as of Nov 6, 2026
ARKG vs Its Peer Average
YTDARKGAvsBPeer average
1D−10.2%−3.4%
1M−11.0%+4.6%
3M+3.7%+3.5%
YTD+54.0%+19.7%
1Y+51.3%+29.0%
3Y+93.8%+75.3%
5Y−41.4%+27.3%
4–3ARKG wins
38 Health care peers · each row scaled to its leader
The Details
ARKG
Risk
1Y4/5our risk indicator
CalmerBumpier
Volatility · 1Y46.90%
Deepest drop · 1Y−27.5%
Lowest point · 5Y−74.8%
52-week range
$44.62
$24.60−24.2% from the high$58.83
ARK ARKG · past-year price moves · as of Nov 6, 2026
ARKG
Fund Facts
Today2014launched Oct 31
Tracks[…]
Exchange · CUSIPCBOE · 00214Q302
StructureETF
Leverage1x
Cost on $10,000$75 a year
Go deeper
ARK ARKG · fund facts · as of Nov 6, 2026
ARKG
Payouts by Year
5Y$0.38per share, Dec 2021
Distribution yield0.0%
PaidOnce a year, in December
Latest ex-date · paidDec 29 · Dec 31, 2021
5 payouts added up$3.02 a share
ARK ARKG · distributions by ex-date · 2017–2021
All Fund FactsDocuments · trading · fees · every payout
Prospectus & Documents
SEC reported portfolio · 2026-07-31 ↗SEC reported portfolio · 2026-04-30 ↗SEC reported portfolio · 2026-01-30 ↗SEC reported portfolio · 2025-10-31 ↗summary prospectus · SEC 497K ↗SEC reported portfolio · 2025-07-31 ↗SEC reported portfolio · 2025-04-30 ↗SEC reported portfolio · 2025-01-31 ↗SEC reported portfolio · 2024-10-31 ↗summary prospectus · SEC 497K ↗SEC reported portfolio · 2024-07-31 ↗SEC reported portfolio · 2024-04-30 ↗SEC reported portfolio · 2024-01-31 ↗SEC reported portfolio · 2023-10-31 ↗summary prospectus · SEC 497K ↗SEC reported portfolio · 2023-07-31 ↗SEC reported portfolio · 2023-04-28 ↗SEC reported portfolio · 2023-01-31 ↗SEC reported portfolio · 2022-10-31 ↗summary prospectus · SEC 497K ↗SEC reported portfolio · 2022-07-29 ↗SEC reported portfolio · 2022-04-29 ↗SEC reported portfolio · 2022-01-31 ↗SEC reported portfolio · 2021-10-29 ↗summary prospectus · SEC 497K ↗SEC reported portfolio · 2021-07-30 ↗SEC reported portfolio · 2021-04-30 ↗summary prospectus · SEC 497K ↗SEC reported portfolio · 2021-01-29 ↗SEC reported portfolio · 2020-10-30 ↗summary prospectus · SEC 497K ↗SEC reported portfolio · 2020-07-31 ↗SEC reported portfolio · 2020-04-30 ↗summary prospectus · SEC 497K ↗summary prospectus · SEC 497K ↗summary prospectus · SEC 497K ↗summary prospectus · SEC 497K ↗summary prospectus · SEC 497K ↗summary prospectus · SEC 497K ↗summary prospectus · SEC 497K ↗
Trading & Liquidity
Net asset value$49.74
Premium / discount[…]
Median spread · 30D[…]
Volume today7.5M
Average volume · 30D5.7M
Shares outstanding[…]
Options[…]
Fees & Costs
Net expense ratio0.75%
Gross expense ratio[…]
Management fee[…]
Cost on $10,000 a year$75.00
Our risk indicator4/5
Estimated yearly cost excludes trading costs and assumes constant assets.
Distributions
| Ex-date | Paid | Per share |
|---|---|---|
| Dec 29, 2021 | Dec 31, 2021 | $0.38 |
| Dec 29, 2020 | Dec 31, 2020 | $0.79 |
| Dec 27, 2019 | Dec 31, 2019 | $1.05 |
| Dec 27, 2018 | Dec 31, 2018 | $0.47 |
| Dec 27, 2017 | Dec 29, 2017 | $0.33 |
Issuer contentFrom ARKHear the strategy from the people behind ARKG.No issuer videos have been published for this fund.Are you the issuer? Claim this fund →